The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease
Abstract Currently, the criteria used to classify patients with SJIA are different from those used for AOSD. However, it has been recognized that the existing terms are too narrow, subdividing the Still's population unnecessarily between pediatric-onset and adult-onset disease and excluding an...
Shranjeno v:
Main Authors: | Peter A. Nigrovic (Author), Fabrizio de Benedetti (Author), Yukiko Kimura (Author), Daniel J. Lovell (Author), Sebastiaan J. Vastert (Author) |
---|---|
Format: | Knjiga |
Izdano: |
BMC,
2024-01-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Podobne knjige/članki
-
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA
od: Grant Schulert, et al.
Izdano: (2024) -
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study
od: Fabrizio de Benedetti, et al.
Izdano: (2024) -
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13-14, 2022
od: Rashmi Sinha, et al.
Izdano: (2024) -
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?
od: Scott W. Canna, et al.
Izdano: (2024) -
NextGen Public Health Surveillance and the Internet of Things (IoT)
od: Kirti Sundar Sahu, et al.
Izdano: (2021)